Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200037/S022

ASSURE Wearable Cardioverter Defibrillator (WCD) System

Kestra Medical Technologies, Inc. · Decision date Nov 4, 2026

MEDTECHLEDGER EXPLANATIONP200037/S022

What did the FDA decide?

The FDA recorded a 30-day notice decision, coded OK30, dated 2026-11-04 for supplement P200037/S022 to the ASSURE Wearable Cardioverter Defibrillator (WCD) System, a wearable automated external defibrillator (product code MVK, cardiovascular specialty) held by Kestra Medical Technologies, Inc. The supplement type is a 30-Day Notice and the recorded reason is a process change affecting manufacturer, sterilizer, packager or supplier.

The recorded statement describes the addition of a second-generation welding system. This entry documents that manufacturing process change within the existing PMA, not a new approval of the whole WCD system, and the source provides no detail on which components the welding system affects, what validation was reviewed, or the basis for the OK30 coding. No supporting documents were included in the source data, so those specifics remain unknown.

The source does not state whether the change alters device performance, labeling or clinical use, and no clinical or legal conclusion should be drawn from the decision code alone.

FDA approval order statement

addition of second-generation welding system
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Nov 4, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P200037/S022
Regulatory pathway
PMA supplement
Product code
MVK
Decision code
OK30
Decision date
Nov 4, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wearable automated external defibrillator.

Product code
MVK
FDA device class
3

For the original device and its historical approval scope, see PMA P200037. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P200037 · Original PMA

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

  2. P200037/S021 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

  3. P200037/S022 received

    Application receipt date recorded by FDA.

  4. P200037/S022 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P200037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200037

Product / regulatory recordCompanyPathwayDecision dateSource
Kestra Medical Technologies, Inc.PMA approvalJul 27, 2021FDA
Kestra Medical Technologies, Inc.PMA supplementSep 28, 2026FDA

Explore the linked device profile

Other records with product code MVK

Product / regulatory recordCompanyPathwayDecision dateSource
Zoll Manufacturing CorporationPMA supplementOct 6, 2026FDA
Zoll Manufacturing CorporationPMA supplementOct 5, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 29, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 9, 2026FDA
Zoll Manufacturing CorporationPMA approvalDec 18, 2001FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kestra Medical Technologies, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3933 Lake Washington Blvd. NE, Suite 200, Kirkland, WA, 98033

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records